Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Syros Pharmaceuticals, Inc. (SYRS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
21 Dec 2023
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,786,427
+102%
904,977
$4.42
$3,999,998.50
SELL
31 Jul 2023
Roth David
Chief Medical Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
7,348
$3.95
$29,024.60
SELL
17 Jul 2023
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
6,661
-9%
689
$3.50
$2,411.50
SELL
5 Jan 2022
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
2,208
$3.47
$7,654.92
SELL
1 Jul 2021
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
1,164
$5.55
$6,460.20
SELL
15 Mar 2021
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
3,628
$9.47
$34,371.67
SELL
16 Feb 2021
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
321,711
-1%
3,750
$12.05
$45,187.50
SELL
8 Feb 2021
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
325,461
-1%
3,750
$13.04
$48,900.00
SELL
16 Nov 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
339,211
-1%
5,990
$8.77
$52,558.09
SELL
19 Oct 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
335,201
-1%
5,673
$8.75
$49,638.75
SELL
15 Oct 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
340,874
-0%
317
$8.75
$2,773.75
SELL
15 Sep 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
341,191
-1%
5,990
$10.39
$62,236.10
SELL
17 Aug 2020
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
15,750
$13.00
$204,750.00
SELL
17 Aug 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
347,181
-1%
5,990
$12.59
$75,414.10
SELL
17 Aug 2020
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,274,616
-11%
159,327
$13.10
$2,086,395.60
SELL
15 Jul 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
353,171
-1%
5,990
$11.85
$70,981.50
SELL
7 Jul 2020
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
1,753
$11.72
$20,538.50
SELL
1 Jul 2020
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,433,943
-0%
4,627
$11.01
$50,965.94
SELL
23 Jun 2020
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,438,570
-9%
154,700
$11.11
$1,718,567.90
SELL
15 Jun 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
359,161
-1%
5,990
$8.75
$52,412.50
SELL
15 May 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
365,151
-1%
5,990
$9.22
$55,242.18
BUY
13 May 2020
Alles Mark J
Director
Syros Pharmaceuticals, Inc.
(SYRS)
10,000
+100%
10,000
$8.86
$88,590.00
SELL
15 Apr 2020
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
371,141
-6%
23,960
$8.75
$209,650.00
SELL
18 Feb 2020
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
1,446
$7.38
$10,674.08
BUY
11 Nov 2019
Springhorn Jeremy P.
Chief Business Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
35,000
+133%
20,000
$4.98
$99,595.80
SELL
15 Aug 2019
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
395,101
-5%
25,000
$10.00
$250,000.00
SELL
15 Jul 2019
ARCH Venture Fund VII, L.P.
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
4,242,051
-1%
63,000
$7.77
$489,280.47
BUY
9 Apr 2019
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,593,270
+50%
533,332
$7.50
$3,999,990.00
SELL
12 Mar 2019
ARCH Venture Fund VII, L.P.
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
4,305,051
-3%
167,503
$7.83
$1,312,380.10
SELL
7 Mar 2019
ARCH Venture Fund VII, L.P.
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
4,472,554
-3%
164,583
$6.80
$1,118,648.50
BUY
31 Jan 2018
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
1,059,938
+24%
209,424
$9.55
$1,999,999.20
BUY
15 Dec 2017
Springhorn Jeremy P.
Chief Business Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
15,000
+100%
15,000
$9.08
$136,260.00
BUY
12 Dec 2017
AKKARAJU SRINIVAS
Director
Syros Pharmaceuticals, Inc.
(SYRS)
830,494
+15%
109,774
$9.03
$991,557.60
SELL
23 Oct 2017
DeSimone Colleen Elizabeth
Principal Accounting Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
550
$16.06
$8,833.27
SELL
14 Aug 2017
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
420,101
-0%
3,282
$22.00
$72,204.00
SELL
7 Aug 2017
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
2,500
$23.59
$58,969.00
SELL
25 Jul 2017
Olson Eric R
Chief Scientific Officer, Officer
Syros Pharmaceuticals, Inc.
(SYRS)
0
-100%
12,500
$21.85
$273,125.00
SELL
25 Jul 2017
Young Richard A
Director
Syros Pharmaceuticals, Inc.
(SYRS)
423,383
-0%
3,282
$22.09
$72,495.77
BUY
6 Jul 2016
Nashat Amir
Director, 10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
1,538,333
+35%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
Polaris Management Co. VII, L.L.C.
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
1,538,333
+35%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
Flagship Ventures Fund IV, L.P.
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
3,674,660
+12%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
Redmile Group, LLC
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
191,869
+179%
432,746
$12.50
$5,409,325.00
BUY
6 Jul 2016
Arch Venture Fund VII LP
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
4,637,137
+9%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
NELSEN ROBERT
Director, 10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
4,637,137
+9%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
AISLING CAPITAL III LP
10% Owner
Syros Pharmaceuticals, Inc.
(SYRS)
908,565
+78%
400,000
$12.50
$5,000,000.00
BUY
6 Jul 2016
Flynn James E
10% Owner, Possible Members of 10% Group
Syros Pharmaceuticals, Inc.
(SYRS)
1,466,654
+37%
400,000
$12.50
$5,000,000.00
Home